Common use of Provera (medroxyprogesterone acetate)
Provera is the brand name for oral medroxyprogesterone acetate, a synthetic form of the hormone progesterone. Clinically, it is used to treat secondary amenorrhea (when periods stop for reasons other than pregnancy), to control abnormal uterine bleeding due to hormonal imbalance (in the absence of structural causes like fibroids or polyps), and to reduce the risk of endometrial hyperplasia in people receiving estrogen therapy during menopause. By providing progestin, Provera stabilizes the endometrium, regulates bleeding, and induces a predictable withdrawal bleed after each treatment course.
Provera is sometimes used off-label for select gynecologic conditions under specialist guidance, but it is not a contraceptive. This is distinct from Depo-Provera, a long-acting injectable form of medroxyprogesterone used for contraception. If contraception is your goal, ask your clinician about appropriate alternatives. Because abnormal bleeding may have multiple causes, evaluation to rule out pregnancy and underlying structural or systemic conditions is important before starting Provera.
Dosage and direction
Always follow your prescriber’s directions. Typical Provera dosage regimens (tablets: 2.5 mg, 5 mg, or 10 mg) include the following examples:
• Secondary amenorrhea: 5–10 mg by mouth once daily for 5–10 days. A withdrawal bleed usually occurs within 3–7 days after the last dose. In some cases, an estrogen “priming” course is given before Provera to build the uterine lining.
• Abnormal uterine bleeding due to hormonal imbalance (no organic pathology): 5–10 mg once daily for 5–10 days. Regimens may be timed to cycle days (for example, starting day 16 or 21), based on your clinician’s plan. Bleeding typically starts a few days after completion.
• Prevention of endometrial hyperplasia in postmenopausal patients on systemic estrogen: 5–10 mg once daily for 12–14 days of each 28‑day cycle (cyclic therapy), or some patients may use lower-dose continuous progestin with daily estrogen, per prescriber guidance.
Take Provera at the same time each day, with or without food, and swallow with water. Do not use Provera if pregnant. Your prescriber may order pregnancy testing before initiating therapy, especially for amenorrhea. Never change your dose or schedule without consulting your clinician, and seek care if bleeding is unusually heavy, prolonged, or accompanied by pain, dizziness, or fainting.
Precautions
Before starting Provera, ensure pregnancy is excluded and discuss your medical history thoroughly. Abnormal uterine bleeding requires evaluation to rule out structural causes (such as fibroids, polyps), infection, coagulation disorders, thyroid disease, or malignancy. If you are using Provera alongside estrogen therapy, your overall cardiovascular and thromboembolic risks should be reviewed, and you should follow the lowest effective dose for the shortest duration consistent with treatment goals.
Provera may cause fluid retention and can affect mood; use caution if you have a history of depression, migraines, asthma, seizure disorders, congestive heart failure, or kidney disease. Report new or worsening headaches, vision changes, chest pain, leg swelling, shortness of breath, jaundice, or severe abdominal pain immediately. If you are diabetic or prediabetic, monitor blood glucose more closely because progestins may impact glycemic control. Provera can affect laboratory tests, including certain liver function and endocrine assays—inform your healthcare team and laboratory personnel that you are taking medroxyprogesterone.
Contraindications
Do not use Provera if you have any of the following: known or suspected pregnancy; undiagnosed abnormal genital bleeding; known, suspected, or history of breast cancer; known or suspected estrogen- or progesterone-dependent malignancy; active or history of deep vein thrombosis, pulmonary embolism, stroke, or myocardial infarction; active liver disease or impaired liver function; hypersensitivity to medroxyprogesterone acetate or any tablet component. Provera should not be used in the setting of a missed abortion. If any contraindication is present or uncertain, seek medical advice before use.
Possible side effects
Common side effects of Provera include breast tenderness, bloating or fluid retention, mild nausea, headache, dizziness, fatigue, mood changes or irritability, acne or oily skin, changes in libido, and changes in menstrual flow such as spotting, breakthrough bleeding, or timing shifts in withdrawal bleeding. Some patients notice mild weight fluctuation. These effects are usually manageable and often improve after the first cycles of therapy.
Less common but serious adverse effects require immediate medical attention: symptoms of a blood clot (leg swelling or pain, sudden chest pain, coughing blood, shortness of breath), stroke-like symptoms (sudden severe headache, weakness or numbness on one side, trouble speaking or vision changes), significant elevation in blood pressure, jaundice or severe right‑upper‑quadrant abdominal pain (possible liver involvement), severe depression, or allergic reactions (rash, hives, facial swelling, difficulty breathing). Although bone mineral density concerns are most associated with long-acting injectable medroxyprogesterone used for contraception, your clinician may still consider bone health if you require prolonged hormonal therapy for other reasons.
Drug interactions
Medroxyprogesterone is metabolized primarily via CYP3A4. Potent CYP3A4 inducers can lower Provera levels and reduce effectiveness, including rifampin, rifabutin, carbamazepine, phenytoin, phenobarbital, primidone, topiramate (at higher doses), enzalutamide, and St. John’s wort. CYP3A4 inhibitors may increase Provera exposure and side effects, such as ketoconazole, itraconazole, clarithromycin, erythromycin, and certain HIV or HCV protease inhibitors. Grapefruit products can also affect CYP3A4 and may alter drug levels—use caution and consult your pharmacist.
Provera may interact with anticoagulants (for example, warfarin), antidiabetic medications, and other hormones. If you use systemic estrogen, your overall clotting risk is higher than with progestin alone, so avoid smoking and monitor for thromboembolic symptoms. Always provide an up-to-date medication and supplement list (including herbals) to your healthcare providers and pharmacist to screen for interactions and plan appropriate monitoring.
Missed dose
If you miss a dose of Provera, take it as soon as you remember unless it is almost time for your next dose. If it is close to the next scheduled dose, skip the missed dose and resume your regular schedule. Do not double up to “catch up.” If vomiting or severe diarrhea occurs soon after dosing, or if you miss multiple doses, contact your clinician for guidance on how to proceed with your regimen.
Overdose
Symptoms of Provera overdose may include nausea, vomiting, dizziness, drowsiness, and breast tenderness. Serious toxicity is uncommon, but any suspected overdose should be treated seriously. Seek medical attention or contact Poison Control (in the U.S., 1‑800‑222‑1222) for immediate advice. Care is supportive and based on symptoms. Bring the medication bottle to the care site so clinicians can verify the strength and quantity taken.
Storage
Store Provera tablets at controlled room temperature (generally 20–25°C/68–77°F), with brief excursions permitted per the manufacturer’s label. Keep tablets in a dry place, protected from moisture and excessive heat or light, and in the original, child‑resistant container. Always keep out of reach of children and pets. Do not use after the expiration date.
U.S. sale and prescription policy
In the United States, Provera (medroxyprogesterone acetate) is a prescription medication. Federal and state regulations require that a licensed clinician determines medical appropriateness and issues a valid prescription before dispensing. Because abnormal uterine bleeding and amenorrhea can signal underlying conditions, professional evaluation remains essential for safe care.
HealthSouth Hospital of Gadsden offers a legal and structured solution for acquiring Provera without a formal, preexisting prescription by integrating access to licensed clinicians. Through telehealth assessment or state‑authorized pharmacist prescribing/collaborative practice arrangements (where permitted), eligible adults can receive an evidence‑based evaluation, an electronic prescription when appropriate, and pharmacist counseling—without needing an in‑person doctor visit. Identity verification, clinical screening, and medication safety checks are standard. Processing and discreet shipping are fast, and refills include ongoing support. Availability varies by state law and clinical criteria; certain conditions may require in‑person evaluation. HealthSouth Hospital of Gadsden prioritizes compliance, privacy, and continuity of care so you can start and maintain Provera therapy safely and conveniently.
